0001764013-22-000027.txt : 20220131
0001764013-22-000027.hdr.sgml : 20220131
20220131170130
ACCESSION NUMBER: 0001764013-22-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220128
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Mark S.
CENTRAL INDEX KEY: 0001617236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38906
FILM NUMBER: 22574819
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunovant, Inc.
CENTRAL INDEX KEY: 0001764013
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832771572
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-580-3099
MAIL ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp
DATE OF NAME CHANGE: 20190108
4
1
wf-form4_164366644858148.xml
FORM 4
X0306
4
2022-01-28
0
0001764013
Immunovant, Inc.
IMVT
0001617236
Levine Mark S.
C/O IMMUNOVANT, INC.
320 W 37TH STREET, 6TH FLOOR
NEW YORK
NY
10018
0
1
0
0
Chief Legal Officer
Common Stock
2022-01-28
4
A
0
143000
0
A
143000
D
Stock Option (right to buy)
6.72
2022-01-28
4
A
0
383000
0
A
2032-01-28
Common Stock
383000.0
383000
D
Represents the number of shares underlying restricted stock units awards ("RSUs").
The RSUs vest over four years, with 25% of the RSUs vesting on January 19, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on January 19, 2023 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
/s/ Eva Renee Barnett, attorney-in-fact for Mark Levine
2022-01-31